Micro-Series | Part 4 | DLL3 in EP-NEC: A New Therapeutic Target Comes Into Focus

Take a closer look at DLL3 as an emerging biomarker and therapeutic target in EP‑NEC. Dr. Pelster discusses the biology behind DLL3 overexpression and the latest clinical data on DLL3‑directed therapies, including bispecific T‑cell engagers.
This episode is part of the Micro-Series, EP-NEC Explained: Diagnosis to Emerging Therapies.
Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

Micro-Series | Part 3 | What’s Next for EP-NEC: New Therapies on the Horizon

With limited durable options available, new approaches are urgently needed in EP-NEC. This episode highlights emerging therapies, including immunotherapy‑based strategies and early clinical trial data shaping future treatment directions.
This episode is part of the Micro-Series, EP-NEC Explained: Diagnosis to Emerging Therapies.
Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

Micro-Series | Part 2 | Treating EP-NEC: What Works, What’s Next

Explore the current EP‑NEC treatment landscape, from first‑line platinum‑based therapy and etoposide to second‑line challenges. Dr. Pelster reviews guideline‑recommended options, sequencing considerations, and why clinical trials are essential in this aggressive disease.
This episode is part of the Micro-Series, EP-NEC Explained: Diagnosis to Emerging Therapies.
Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

Micro-Series | Part 1 | Recognizing EP-NEC: How It Presents and How to Diagnose It

Dr. Meredith Pelster introduces extrapulmonary neuroendocrine carcinoma (EP‑NEC), outlining how patients present and what distinguishes this rare disease. Learn the key elements of diagnostic workup, including pathology, imaging, and features that differentiate EP‑NEC from other neuroendocrine tumors.
This episode is part of the Micro-Series, EP-NEC Explained: Diagnosis to Emerging Therapies.
Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.